Siemens Healthineers to Acquire Novartis’ Radiodiagnostic Manufacturing and Distribution Network
Shots:
- Siemens Healthineers has agreed to acquire Novartis' Advanced Accelerator Applications (AAA) diagnostic division for over $223M (€200M)
- The acquisition will enhance Siemens Healthineers’ spot in medical imaging sector (specifically in radioactive chemicals production for PET scans) to improve cancer, heart & neurological disorder diagnostics plus expand its European market presence
- The transaction will conclude in Q4’24, contingent upon regulatory approval and negotiations with Novartis’s works council. Siemens Healthineers will continue partnering with Novartis in radioligand therapy
Ref: Radiology Business | Image: Siemens Healthineers & Novartis
Related News:- Siemens Healthineers’s CLINITEST COVID-19 Antigen Test Receives the US FDA's EUA for the Prevention of COVID-19
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
